LTI-03

· Rein Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LTI-03, covering 2025-07-31 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]